|
1
|
Cecconi M, Evans L, Levy M and Rhodes A:
Sepsis and septic shock. Lancet. 392:75–87. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (sepsis-3). JAMA.
315:801–810. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gotts JE and Matthay MA: Sepsis:
Pathophysiology and clinical management. BMJ.
353(i1585)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ince C, Mayeux PR, Nguyen T, Gomez H,
Kellum JA, Ospina-Tascón GA, Hernandez G, Murray P and De Backer D:
ADQI XIV Workgroup. The endothelium in sepsis. Shock. 45:259–270.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Radeva MY and Waschke J: Mind the gap:
Mechanisms regulating the endothelial barrier. Acta Physiol (Oxf):
222, 2018. doi: 10.1111/apha.12860.
|
|
6
|
Millar FR, Summers C, Griffiths MJ,
Toshner MR and Proudfoot AG: The pulmonary endothelium in acute
respiratory distress syndrome: Insights and therapeutic
opportunities. Thorax. 71:462–473. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Weerink MAS, Struys MMRF, Hannivoort LN,
Barends CRM, Absalom AR and Colin P: Clinical pharmacokinetics and
pharmacodynamics of dexmedetomidine. Clin Pharmacokinet.
56:893–913. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Meng L, Li L, Lu S, Li K, Su Z, Wang Y,
Fan X, Li X and Zhao G: The protective effect of dexmedetomidine on
LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB
and PI3K/Akt/mTOR pathways. Mol Immunol. 94:7–17. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hu H, Shi D, Hu C, Yuan X, Zhang J and Sun
H: Dexmedetomidine mitigates CLP-stimulated acute lung injury via
restraining the RAGE pathway. Am J Transl Res. 9:5245–5258.
2017.PubMed/NCBI
|
|
10
|
Li B, Li Y, Tian S, Wang H, Wu H, Zhang A
and Gao C: Anti-inflammatory effects of perioperative
dexmedetomidine administered as an adjunct to general anesthesia: A
meta-analysis. Sci Rep. 5(12342)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang XW, Cao JB, Lv BS, Mi WD, Wang ZQ,
Zhang C, Wang HL and Xu Z: Effect of perioperative dexmedetomidine
on the endocrine modulators of stress response: A meta-analysis.
Clin Exp Pharmacol Physiol. 42:828–836. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
International guidelines on animal
welfare. 156: 723-723, 2005.
|
|
13
|
Rittirsch D, Huber-Lang MS, Flierl MA and
Ward PA: Immunodesign of experimental sepsis by cecal ligation and
puncture. Nat Protoc. 4:31–36. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu X, Wang N, Wei G, Fan S, Lu Y, Zhu Y,
Chen Q, Huang M, Zhou H and Zheng J: Consistency and
pathophysiological characterization of a rat polymicrobial sepsis
model via the improved cecal ligation and puncture surgery. Int
Immunopharmacol. 32:66–75. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen Q, Yi B, Ma J, Ning J, Wu L, Ma D, Lu
K and Gu J: α22-adrenoreceptor modulated FAK pathway induced by
dexmedetomidine attenuates pulmonary microvascular
hyper-permeability following kidney injury. Oncotarget.
7:55990–56001. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mai SHC, Sharma N, Kwong AC, Dwivedi DJ,
Khan M, Grin PM, Fox-Robichaud AE and Liaw PC: Body temperature and
mouse scoring systems as surrogate markers of death in cecal
ligation and puncture sepsis. Intensive Care Med Exp.
6(20)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cox RA: Endothelin-1 and acute lung injury
in sheeps with smoke inhalation and burn injury[D]. Galveston: The
University of Texas,Graduate School of Biomedical Sciences: 18-19,
2003.
|
|
18
|
Jin Y, Yu G, Peng P, Zhang Y and Xin X:
Down-regulated expression of AQP5 on lung in rat DIC model induced
by LPS and its effect on the development of pulmonary edema. Pulm
Pharmacol Ther. 26:661–665. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Buras JA, Holzmann B and Sitkovsky M:
Animal models of sepsis: Setting the stage. Nat Rev Drug Discov.
4:854–865. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Cruz FF, Rocco PR and Pelosi P:
Anti-inflammatory properties of anesthetic agents. Crit Care.
21(67)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yeh YC, Wu CY, Cheng YJ, Liu CM, Hsiao JK,
Chan WS, Wu ZG, Yu LC and Sun WZ: Effects of Dexmedetomidine on
intestinal microcirculation and intestinal epithelial barrier in
endotoxemic rats. Anesthesiology. 125:355–367. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Miranda ML, Balarini MM and Bouskela E:
Dexmedetomidine attenuates the microcirculatory derangements evoked
by experimental sepsis. Anesthesiology. 122:619–630.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu Y, Liu Y, Huang H, Zhu Y, Zhang Y, Lu F
and Zhou C, Huang L, Li X and Zhou C: Dexmedetomidine inhibits
inflammatory reaction in lung tissues of septic rats by suppressing
TLR4/NF-κB pathway. Mediators Inflamm. 2013(562154)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ma Y, Yu XY and Wang Y: Dose-related
effects of dexmedetomidine on immunomodulation and mortality to
septic shock in rats. World J Emerg Med. 9:56–63. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Moss A: The angiopoietin: Tie 2
interaction: A potential target for future therapies in human
vascular disease. Cytokine Growth Factor Rev. 24:579–592.
2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Parikh SM: Dysregulation of the
angiopoietin-Tie-2 axis in sepsis and ARDS. Virulence. 4:517–524.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ricciuto DR, dos Santos CC, Hawkes M,
Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud
A, Kahnamoui K, et al: Angiopoietin-1 and 2 as clinically
informative prognostic biomarkers of morbidity and mortality in
severe sepsis. Crit Care Med. 39:702–710. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Han S, Lee SJ, Kim KE, Lee HS, Oh N, Park
I, Ko E, Oh SJ, Lee YS, Kim D, et al: Amelioration of sepsis by
TIE2 activation-induced vascular protection. Sci Transl Med.
8(335ra355)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Poli-de-Figueiredo LF, Garrido AG,
Nakagawa N and Sannomiya P: Experimental models of sepsis and their
clinical relevance. Shock. 30 (Suppl 1):S53–S59. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chousterman BG, Swirski FK and Weber GF:
Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol.
39:517–528. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
van der Poll T, van de Veerdonk FL,
Scicluna BP and Netea MG: The immunopathology of sepsis and
potential therapeutic targets. Nat Rev Immunol. 17:407–420.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Levi M and van der Poll T: Coagulation and
sepsis. Thromb Res. 149:38–44. 2017.PubMed/NCBI View Article : Google Scholar
|
